Deva Pharmaceutical

DEVA ranked in 21st place in a list of highest spenders in R&D in Turkey, published by Turkish Time based on the results of their “R&D 250, Top R&D Spenders of Turkey”* survey. In the pharmaceutical industry, DEVA topped the list of highest spenders in R&D. (Ar-GE 250, 2018) We are conducting projects to raise awareness on healthy living and certain diseases. We have continued supporting our National Athlete ahika Ercümen – who was diagnosed with allergic asthma in childhood and subsequently broke the world record in free diving – in her rts toward breaking new records, and we are happy to be continuing. At DEVA, we have been working for over 60 years for better health for everyone around the world, in the recognition that access to a healthy life is a human right. In 2019, we have further enhanced our product portfolio with innovative equivalent products in hematology, oncology, cardiology, respiratory and ophthalmology therapy areas. We have stepped into new territories with our products for pulmonary arterial hypertension and multiple sclerosis, which are considered to be specialty areas For over six decades, we have been working for a healthier future, drawing on our long history and growing strength as a local, strong and global pharmaceutical company with a global vision.